Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90

Allogeneic natural killer (aNK) cell adoptive therapy has the potential to dramatically impact clinical outcomes of glioblastoma multiforme (GBM). However, in order to exert therapeutic activity, NK cells require tumor expression of ligands for activating receptors, such as MHC Class I peptide A/B (...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Tanmoy, van Vliet, Amanda A., Cui, Chunxiao, Macias, Jorge Jimenez, Kulkarni, Arpita, Pham, Luu Nhat, Lawler, Sean, Spanholtz, Jan, Georgoudaki, Anna-Maria, Duru, Adil Doganay, Goldman, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673718/
https://www.ncbi.nlm.nih.gov/pubmed/34926577
http://dx.doi.org/10.3389/fmolb.2021.754443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673718/
https://www.ncbi.nlm.nih.gov/pubmed/34926577
http://dx.doi.org/10.3389/fmolb.2021.754443

Ejemplares similares